Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Histone modification is key in treating chronic inflammatory skin diseases.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Examining Survivin levels may help understand premature greying of hair.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Notch-related genes play a key role in the development and cycling of hair follicles.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.